Management of Borderline Resectable Pancreatic Cancer

被引:49
作者
Katz, Matthew H. G. [1 ]
Crane, Christopher H. [2 ]
Varadhachary, Gauri [3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Med Oncol, Houston, TX 77030 USA
关键词
GEMCITABINE-BASED CHEMORADIATION; EXPERT CONSENSUS STATEMENT; PREOPERATIVE GEMCITABINE; RADIATION-THERAPY; MULTIINSTITUTIONAL PHASE-2; NEOADJUVANT GEMCITABINE; CONTROLLED-TRIAL; DOSE-ESCALATION; ADENOCARCINOMA; CHEMOTHERAPY;
D O I
10.1016/j.semradonc.2013.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Borderline resectable pancreatic cancers are those that, although technically resectable, are at high risk for margin-positive resection following surgery de novo. Generally, such cancers are characterized by localized primary tumors that involve the mesenteric vasculature to a limited degree and that may require venous or hepatic arterial resection at pancreatectomy. In this article, we review diagnosis and staging algorithms, pretreatment strategies, and multidisciplinary treatment protocols for patients with this stage of disease. The rationale for and results following treatment with neoadjuvant chemotherapy and chemoradiation and subsequent surgical resection of the primary tumor are described in detail and existing data are reviewed. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 42 条
  • [1] Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study
    Aadam, A. Aziz
    Evans, Douglas B.
    Khan, Abdul
    Oh, Young
    Dua, Kulwinder
    [J]. GASTROINTESTINAL ENDOSCOPY, 2012, 76 (01) : 67 - 75
  • [2] Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement
    Abrams, Ross A.
    Lowy, Andrew M.
    O'Reilly, Eileen M.
    Wolff, Robert A.
    Picozzi, Vincent J.
    Pisters, Peter W. T.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) : 1751 - 1756
  • [3] A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer
    Ben-Josef, Edgar
    Schipper, Mathew
    Francis, Isaac R.
    Hadley, Scott
    Ten-Haken, Randall
    Lawrence, Theodore
    Normolle, Daniel
    Simeone, Diane M.
    Sonnenday, Christopher
    Abrams, Ross
    Leslie, William
    Khan, Gazala
    Zalupski, Mark M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05): : 1166 - 1171
  • [4] Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1067/msy.1999.98741
  • [5] Dose escalation with proton or photon radiation treatment for pancreatic cancer
    Bouchard, Myriam
    Amos, Richard A.
    Briere, Tina M.
    Beddar, Sam
    Crane, Christopher H.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 92 (02) : 238 - 243
  • [6] A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma
    Brown, Michael W.
    Ning, Holly
    Arora, Barbara
    Albert, Paul S.
    Poggi, Matthew
    Camphausen, Kevin
    Citrin, Deborah
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01): : 274 - 283
  • [7] Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
    Callery, Mark P.
    Chang, Kenneth J.
    Fishman, Elliot K.
    Talamonti, Mark S.
    Traverso, L. William
    Linehan, David C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) : 1727 - 1733
  • [8] Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated
    Chuong, Michael D.
    Springett, Gregory M.
    Freilich, Jessica M.
    Park, Catherine K.
    Weber, Jill M.
    Mellon, Eric A.
    Hodul, Pamela J.
    Malafa, Mokenge P.
    Meredith, Kenneth L.
    Hoffe, Sarah E.
    Shridhar, Ravi
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (03): : 516 - 522
  • [9] FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
    Conroy, Thierry
    Desseigne, Francoise
    Ychou, Marc
    Bouche, Olivier
    Guimbaud, Rosine
    Becouarn, Yves
    Adenis, Antoine
    Raoul, Jean-Luc
    Gourgou-Bourgade, Sophie
    de la Fouchardiere, Christelle
    Bennouna, Jaafar
    Bachet, Jean-Baptiste
    Khemissa-Akouz, Faiza
    Pere-Verge, Denis
    Delbaldo, Catherine
    Assenat, Eric
    Chauffert, Bruno
    Michel, Pierre
    Montoto-Grillot, Christine
    Ducreux, Michel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) : 1817 - 1825
  • [10] Staging Laparoscopy Enhances the Detection of Occult Metastases in Patients With Pancreatic Adenocarcinoma
    Contreras, Carlo M.
    Stanelle, Eric J.
    Mansour, John
    Hinshaw, J. Louis
    Rikkers, Layton F.
    Rettammel, Robert
    Mahvi, David M.
    Cho, Clifford S.
    Weber, Sharon M.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (08) : 663 - 669